BIRC5 and colorectal cancer: A secondary metabolite Prodigiosin and Omega-3 fatty acids (docosahexaenoic and eicosapentaenoic acid), downregulate survivin expression through p53 dependent pathways in ALL, AML, breast, liver and colorectal cancers [146–148].